Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging double-blind study of oral lubiprostone in chronic idiopathic constipation
jRCT2080220460Phase 2
- Sponsor
- Sucampo
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in functional constipation (FC) comparing Lubiprostone with Placebo (2 arms).
02
Drugs
cobiprostone
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on jRCT2080220460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220460.